Literature DB >> 24145708

[Abnormal liver function tests in the intensive care unit].

A Koch1, K Streetz, J Tischendorf, C Trautwein, F Tacke.   

Abstract

Abnormal liver biochemical and function tests are found in the majority of critically ill patients and are associated with increased mortality. Frequent causes for elevated liver function tests in the intensive care unit (ICU) are acute hepatic dysfunction due to acute hepatitis, acute liver failure (ALF), and drug-induced liver injury (DILI). Furthermore, exacerbations of pre-existing liver diseases (acute on chronic) and secondary liver injury during critical diseases such as sepsis, right heart failure, or cardiogenic shock, resulting in ischemic or hypoxic hepatitis, need to be considered. Elevated liver enzymes may also reflect a complication of ICU treatment measures like drug-related hepatotoxicity, secondary sclerosing cholangitis in critically ill patients (SC-CIP), or related to parenteral nutrition. Comprehensive diagnostic evaluation is essential to identify the underlying etiology of abnormal liver function tests and to initiate the appropriate therapeutic strategies.

Entities:  

Mesh:

Year:  2013        PMID: 24145708     DOI: 10.1007/s00063-013-0287-2

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  25 in total

Review 1.  Sepsis and cholestasis.

Authors:  Richard H Moseley
Journal:  Clin Liver Dis       Date:  2004-02       Impact factor: 6.126

Review 2.  Drug-induced liver injury: Hy's rule revisited.

Authors:  Einar Björnsson
Journal:  Clin Pharmacol Ther       Date:  2006-06       Impact factor: 6.875

Review 3.  Pathophysiology of increased intestinal permeability in obstructive jaundice.

Authors:  Stelios F Assimakopoulos; Chrisoula D Scopa; Constantine E Vagianos
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

Review 4.  Molecular pathogenesis of cholestasis.

Authors:  M Trauner; P J Meier; J L Boyer
Journal:  N Engl J Med       Date:  1998-10-22       Impact factor: 91.245

Review 5.  Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response.

Authors:  W W Lautt
Journal:  Am J Physiol       Date:  1985-11

Review 6.  Risk factors for idiosyncratic drug-induced liver injury.

Authors:  Naga Chalasani; Einar Björnsson
Journal:  Gastroenterology       Date:  2010-04-12       Impact factor: 22.682

Review 7.  Ischemic cholangiopathy after liver transplantation.

Authors:  Andrew M Cameron; Ronald W Busuttil
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2005-11

8.  'Liver function tests' on the intensive care unit: a prospective, observational study.

Authors:  S J Thomson; M L Cowan; I Johnston; S Musa; M Grounds; T M Rahman
Journal:  Intensive Care Med       Date:  2009-06-10       Impact factor: 17.440

9.  Liver histology in ICU patients dying from sepsis: a clinico-pathological study.

Authors:  John Koskinas; Ilias P Gomatos; Dina G Tiniakos; Nikolaos Memos; Maria Boutsikou; Aspasia Garatzioti; Athanasios Archimandritis; Alexander Betrosian
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

10.  Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU.

Authors:  Alexander Koch; Andreas Horn; Hanna Dückers; Eray Yagmur; Edouard Sanson; Jan Bruensing; Lukas Buendgens; Sebastian Voigt; Christian Trautwein; Frank Tacke
Journal:  Crit Care       Date:  2011-11-14       Impact factor: 9.097

View more
  4 in total

Review 1.  [Hepatic dysfunction in patients with cardiogenic shock].

Authors:  Philipp Kasper; Frank Tacke; Hans-Michael Steffen; Guido Michels
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-09-19       Impact factor: 0.840

Review 2.  Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis.

Authors:  Mohammad Shehab; Fatema Alrashed; Sameera Shuaibi; Dhuha Alajmi; Alan Barkun
Journal:  BMJ Open Gastroenterol       Date:  2021-03

3.  Drug-Induced Liver Injury in Critically Ill Children Taking Antiepileptic Drugs: A Retrospective Study.

Authors:  Kannan Sridharan; Amal Al Daylami; Reema Ajjawi; Husain A M Al Ajooz
Journal:  Curr Ther Res Clin Exp       Date:  2020-03-09

4.  Incidence, Clinical Characteristics and Outcomes of Early Hyperbilirubinemia in Critically Ill Patients: Insights From the MARS Study.

Authors:  Jenny Juschten; Lieuwe D J Bos; Harm-Jan de Grooth; Ulrich Beuers; Armand R J Girbes; Nicole P Juffermans; Stephan A Loer; Tom van der Poll; Olaf L Cremer; Marc J M Bonten; Marcus J Schultz; Pieter Roel Tuinman
Journal:  Shock       Date:  2022-02-01       Impact factor: 3.454

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.